ArticleJournal of blood medicine2022

Evaluation of Minimal Optimal Dose of Intravenous Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia and Risk of Transient Hyperferritinemia.

Ahmad A Alharbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.